This test revealed matching RNA levels of OP18 and UPK1A, respectively, and suggested the validity of this cell-based system to study the role of OP18 for malignant cell proliferation of bladder cancer (Fig 1B and 1C). The gene discussed is UPK1A; the disease is urinary bladder carcinoma.